Molecular Compatibility in Chinese Medicine for Cancer Treatment and Drug Development: From Traditional Wisdom to Innovative Therapeutics
Feature Article|Updated:2026-02-14
|
Molecular Compatibility in Chinese Medicine for Cancer Treatment and Drug Development: From Traditional Wisdom to Innovative Therapeutics
Chinese Journal of Integrative MedicineVol. 32, Issue 2, Pages: 99-110(2026)
Affiliations:
1.School of Pharmacy, Hangzhou Normal University, Hangzhou(311121), China
2.Zhejiang Provincial Key Laboratory of Anti-Cancer Chinese Medicines and Natural Medicines, Hangzhou(311121), China
3.Engineering Research Center of Development and Application of Traditional Chinese Medicine from Zhejiang Province, Hangzhou (311121), China
4.State Key Laboratory of Southwestern Chinese Medicine Resources, School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu(611137), China
5.TCM Prevention and Treatment of Metabolic and Chronic Diseases Key Laboratory of Sichuan Province, Hospital of Chengdu University of Traditional Chinese Medicine, Chengdu (610072), China
6.Sichuan Provincal Engineering Technology Research Center of Natural Small Molecule Drug, Tianfu TCM Innovation Harbour, Chengdu University of Traditional Chinese Medicine, Chengdu (611930), China
Author bio:
Prof. ZHENG Chuan, E-mail: zhengchuan@cdutcm.edu.cn;
ZHANG Ruo-nan, YOU Yu, GAO Quan, et al. Molecular Compatibility in Chinese Medicine for Cancer Treatment and Drug Development: From Traditional Wisdom to Innovative Therapeutics[J]. Chinese Journal of Integrative Medicine, 2026, 32(2): 99-110.
DOI:
ZHANG Ruo-nan, YOU Yu, GAO Quan, et al. Molecular Compatibility in Chinese Medicine for Cancer Treatment and Drug Development: From Traditional Wisdom to Innovative Therapeutics[J]. Chinese Journal of Integrative Medicine, 2026, 32(2): 99-110. DOI: 10.1007/s11655-025-4152-y.
Molecular Compatibility in Chinese Medicine for Cancer Treatment and Drug Development: From Traditional Wisdom to Innovative Therapeutics
摘要
Abstract
关键词
Keywords
references
The trial reading is over, you can activate your VIP account to continue reading.